Pfizer (PFE) 10-Q2015 Q1 Quarterly report

Filed: 7 May 15, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: Andrx, anticoagulant, antirheumatic, Avastin, avelumab, axial, Belgium, born, cautioned, characterizing, Chinese, composed, correlation, corroborated, cycle, deferral, deficit, doublet, draft, electronic, embedded, feature, FL, footprint, frequency, gave, gestational, GHD, Goldman, Governor, hormone, Hospira, host, hybrid, Ibrance, infusion, Inspra, intensified, intercompany, IPD, KGaA, landmark, leader, leveraging, lift, methodology, Mexican, Ministry, mutation, NOAC, nonradiographic, notice, NVAF, OPKO, pack, partner, Perrigo, peso, pose, postmarketing, preliminarily, prepaid, principle, profit, Rapamune, Reauthorization, renminbi, repurchase, repurchased, repurchasing, resume, rheumatologist, Rodino, row, sensitivity, SGA, show, SIMADI, Similarly, split, stage, starter, steadily, stipulated, sympathetic, theoretically, tobacco, traditional, turn, undue, wage, waiting, waiver, warfarin, week

Removed: accountability, accountable, accurate, addressed, adjustment, affirmed, Alembic, Alzheimer, Animal, anticompetitive, Appellate, arrive, aspect, assurance, atrophy, attempted, award, awarded, bapineuzumab, Beijing, Boehringer, bone, breached, broader, budget, build, burden, Capsugel, cartilage, ceiling, CERCLA, Chemistry, Clara, clarified, classification, closure, cold, comprise, CONBRIZA, conspired, constituted, consumption, convert, Corrupt, County, Critical, crystalline, CTA, cumulative, database, derecognition, derecognized, designation, designing, Detrol, disaggregate, discipline, discounted, disparate, disposable, disposition, diversity, divested, Divestiture, dose, downturn, earlier, effected, effectively, eliminate, elimination, ELT, ending, enhancing, ensuring, entitlement, entrant, episode, equal, exchanged, exclusively, exercised, expediting, expensed, extension, extraordinary, fact, factored, fiduciary, file, fit, flexibility, flexible, flu, focusing, formation, found, Foundation, fracture, fulfill, gabapentin, ground, headcount, Hisun, holistic, hospital, Iceland, immunology, incidence, indirect, Ingelheim, inherent, initially, integrated, intensely, intensity, IPO, IREF, Ischemia, jury, LA, lengthy, limit, lingering, Mark, matrix, media, meeting, mg, migrate, misappropriate, misleading, moderately, moved, multidose, natural, Nicorette, nominal, Norway, noted, Nutrition, occurred, offer, offering, opted, option, outpace, page, paragraph, parity, partly, permanently, perspective, population, prejudgment, present, preserved, proceed, prolonged, proprietary, PT, quickly, rapidly, reallocated, reassessing, recall, receiving, recovery, redeploy, reduced, Remoxy, render, repealing, replace, replacing, requesting, restated, resubmission, resubmitted, retailer, retained, retirement, retrial, returned, routinely, run, Santa, secondary, Sherman, short, source, SPC, stability, stay, stream, subjected, submitting, subsequent, suicide, Superfund, supplement, suspended, systematically, talent, Team, testing, transfer, transform, unit, upheld, vacated, vaginal, validation, venture, verdict, vi, viewing, vii, vulvar, weather, Wockhardt, Zhejiang

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

PFE similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 15

Accountants' Acknowledgment

To the Board of Directors and the Shareholders of Pfizer Inc.:

We hereby acknowledge our awareness of the use therein of our report dated May 7, 2015, included within the Quarterly Report on Form 10-Q of Pfizer Inc. for the quarter ended March 29, 2015, in the following Registration Statements:

-Form S-8 dated October 27, 1983 (File No. 2-87473),

-Form S-8 dated March 22, 1990 (File No. 33-34139),

-Form S-8 dated January 24, 1991 (File No. 33-38708),

-Form S-8 dated November 18, 1991 (File No. 33-44053),

-Form S-8 dated May 27, 1993 (File No. 33-49631),

-Form S-8 dated May 19, 1994 (File No. 33-53713),

-Form S-8 dated October 5, 1994 (File No. 33-55771),

-Form S-8 dated December 20, 1994 (File No. 33-56979),

-Form S-8 dated March 29, 1996 (File No. 333-02061),

-Form S-8 dated September 25, 1997 (File No. 333-36371),

-Form S-8 dated April 24, 1998 (File No. 333-50899),

-Form S-8 dated April 22, 1999 (File No. 333-76839),

-Form S-8 dated June 19, 2000 (File No. 333-39610),

-Form S-8 dated June 19, 2000 (File No. 333-39606),

-Form S-8 dated April 27, 2001 (File No. 333-59660),

-Form S-8 dated April 27, 2001 (File No. 333-59654),

-Form S-8 dated April 16, 2003 (File No. 333-104581),

-Form S-8 dated April 16, 2003 (File No. 333-104582),

-Form S-8 dated November 18, 2003 (File No. 333-110571),

-Form S-8 dated December 18, 2003 (File No. 333-111333),

-Form S-8 dated April 26, 2004 (File No. 333-114852),

-Form S-8 dated March 1, 2007 (File No. 333-140987),

-Form S-4 dated March 27, 2009 (File No. 333-158237),

-Form S-8 dated October 16, 2009 (File No. 333-162519),

-Form S-8 dated October 16, 2009 (File No. 333-162520),

-Form S-8 dated October 16, 2009 (File No. 333-162521),

-Form S-8 dated March 1, 2010 (File No. 333-165121),

-Form S-3ASR dated March 2, 2015 (File No. 333-202430), and

-Form S-8 dated March 2, 2015 (File No. 333-202437).

Pursuant to Rule 436 under the Securities Act of 1933 (the Act), such report is not considered a part of a registration statement prepared or certified by an independent registered public accounting firm, or a report prepared or certified by an independent registered public accounting firm within the meaning of Sections 7 and 11 of the Act.

/s/KPMG LLP

New York, New York

May 7, 2015